WHO /Tom Pietrasik
Sanitation staff clean playground apparatus at the private Anmol Jyoti School in Kathmandu,Nepal.
© Credits

Severe Acute Respiratory Syndrome (SARS)


    Severe acute respiratory syndrome (SARS) is a viral respiratory disease caused by a SARS-associated coronavirus. It was first identified at the end of February 2003 during an outbreak that emerged in China and spread to 4 other countries. WHO co-ordinated the international investigation with the assistance of the Global Outbreak Alert and Response Network (GOARN) and worked closely with health authorities in affected countries to provide epidemiological, clinical and logistical support and to bring the outbreak under control.

    SARS is an airborne virus and can spread through small droplets of saliva in a similar way to the cold and influenza. It was the first severe and readily transmissible new disease to emerge in the 21st century and showed a clear capacity to spread along the routes of international air travel.

    SARS can also be spread indirectly via surfaces that have been touched by someone who is infected with the virus.

    Most patients identified with SARS were previously healthy adults aged 25–70 years. A few suspected cases of SARS have been reported among children under 15 years. The case fatality among persons with illness meeting the current WHO case definition for probable and suspected cases of SARS is around 3%.



    The incubation period of SARS is usually 2-7 days but may be as long as 10 days.

    The first symptom of the illness is generally fever (>38°C), which is often high, and sometimes associated with chills and rigors. It may also be accompanied by other symptoms including headache, malaise, and muscle pain. At the onset of illness, some cases have mild respiratory symptoms. Typically, rash and neurologic or gastrointestinal findings are absent, although a few patients have reported diarrhoea during the early febrile stage.

    After 3-7 days, a lower respiratory phase begins with the onset of a dry, non-productive cough or dyspnoea (shortness of breath) that may be accompanied by, or progress to, hypoxemia (low blood oxygen levels). In 10–20% of cases, the respiratory illness is severe enough to require intubation and mechanical ventilation. Chest radiographs may be normal throughout the course of illness, though not for all patients. The white blood cell count is often decreased early in the disease, and many people have low platelet counts at the peak of the disease. 



    There is no cure or vaccine for SARS and treatment should be supportive and based on the patient’s symptoms.

    Controlling outbreaks relies on containment measures including:

    • prompt detection of cases through good surveillance networks and including an early warning system;
    • isolation of suspected of probably cases;
    • tracing to identify both the source of the infection and contacts of those who are sick and may be at risk of contracting the virus;
    • quarantine of suspected contacts for 10 days;
    • exit screening for outgoing passengers from areas with recent local transmission by asking questions and temperature measurement; and
    • disinfection of aircraft and cruise vessels having SARS cases on board using WHO guidelines.

    Personal preventive measures to prevent spread of the virus include frequent hand washing using soap or alcohol-based disinfectants. For those with a high risk of contracting the disease, such as health care workers, use of personal protective equipment, including a mask, goggles and an apron is mandatory.  Whenever possible, household contacts should also wear a mask.



    All →


    All →
    Integrated sentinel surveillance of influenza and SARS-CoV-2 and the development of the Global Influenza Surveillance and Response System Plus: virtual meeting, 12 – 14 October 2021

    The first WHO consultation from 6 – 8 October 2020 developed interim guidance of epidemiological and laboratory surveillance of influenza and SARS-CoV-2...

    First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection,...

    Severe Acute Respiratory Infections Treatment Centre

    This is the first edition of the practical manual to set up and manage a severe acute respiratory infection (SARI) treatment centre and a SARI screening...

    Objectives of the callTo discuss the theoretical potential for cross-reactivity between nCoV and SARS based on available sequence/modelling dataTo obtain...

    Meeting reports

    All →
    Blood safety and laboratory technology

    These guidelines are constantly reviewed and updated, as new information becomes available. These are compiled to provide a generic basis on which national...

    HCV tests on blood samples.

    The below table provides the first compilation of data on resistance of the SARS Coronavirus against environmental factors and disinfectants. This information...

    These landscape documents have been prepared by WHO for information purposes only concerning the 2019-2020 global of the novel coronavirus. Inclusion of...